C12N 2760/18845
Special targeting system for viral vectors
C12N2760/18845 (Special targeting system for viral vectors) appears on 6 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 13
- Assignees
- 11
- Inventors
- 43
- Latest grant
- 7 Jul 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Lentiviral vectors7 Jul 2020US 10,704,061 B2ID Pharma Co., Ltd.
- Somatic cell nuclear transfer methods24 Dec 2019US 10,513,709 B2New York Stem Cell Foundation, Inc.
- Somatic cell nuclear transfer methods20 Feb 2018US 9,896,699 B2New York Stem Cell Foundation, Inc.
- Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell5 Mar 2013US 8,388,979 B2Ishihara Sangyo Kaisha, Ltd.
- Mutant paramyxovirus and method for production thereof28 Dec 2010US 7,858,356 B2Genomidea Inc.
- Rna virus-derived chimeric envelope protein and rna virus vector having same6 Nov 2025US 2025/0340899 A1Tokiwa-Bio Inc.
- Combination treatment25 Jan 2024US 2024/0024515 A1Boehringer Ingelheim International GmbH
- Somatic cell nuclear transfer methods23 Aug 2018US 2018/0237799 A1New York Stem Cell Foundation, Inc.
- Lentiviral vectors6 Apr 2017US 2017/0096684 A1ID Pharma Co., Ltd.
- Somatic cell nuclear transfer methods28 Jan 2016US 2016/0024528 A1New York Stem Cell Foundation, Inc.
Most cited
By later US patents